International Journal of Legal Medicine

, Volume 132, Issue 2, pp 531–539 | Cite as

Acute phase response after fatal traumatic brain injury

  • Benjamin Ondruschka
  • Sandra Schuch
  • Dirk Pohlers
  • Heike Franke
  • Jan Dreßler
Original Article


An inflammatory response occurring after fatal traumatic brain injury (TBI) initiates time-dependent cascades of acute phase response. This may offer the potential to monitor postmortem biomarker levels of several pro-inflammatory cytokines to gain information about the cause of death and the trauma survival time. Cerebrospinal fluid (CSF) and serum samples were collected from forensic autopsies of 95 adult cadavers after postmortem intervals up to 6 days. The cases were divided according to their cause of death into fatal TBI (n = 46) with different survival times and age- and gender-matching non-TBI fatalities as controls (n = 49). Quantitative marker levels of interleukin-6 (IL-6), ferritin, soluble tumor necrosis factor receptor type 1, C-reactive protein, and lactate dehydrogenase were analyzed using immunoassays. Standardized statistical tests were performed to differentiate causes of death and survival time of TBI cases. The CSF IL-6, ferritin, and LDH levels after TBI were significantly higher than those in the controls (p < 0.001). Only serum IL-6 values showed comparable differences (p < 0.05). Both CSF and serum ferritin levels were discriminative between early and delayed death after TBI (p < 0.05). There were partly distinctive correlations between marker levels in both fluids with rising values after longer survival. There were up to moderate correlation between the marker levels and the postmortem interval due to postmortem hemolysis. However, neither CSF nor serum level ranges were affected by the age or gender of the subjects. This study is the first to measure all five proteins systematically in postmortem trauma cases. Ferritin and IL-6 proved themselves to be interesting postmortem biomarkers to provide specific information on the injury pattern and the survival time of traumatic fatalities. Such forensic investigations could serve as inexpensive and fast laboratory tests.


Acute phase response Cytokines Fatal traumatic brain injury Inflammation Postmortem biochemistry 



The authors would like to cordially thank Philip Saunders (Language Support Services; Berlin, Germany) for proofreading this paper as a native speaker.

Funding information

This work was partly supported by the German Ministry of Defense.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

414_2017_1768_MOESM1_ESM.xlsx (16 kb)
Table S1: Clinical and pathological characteristics of the individuals died from traumatic brain injury. ISS, injury severity score; GCS, Glasgow coma scale; CPR, cardiopulmonary resuscitation; g; grams; h, hours; PMI, postmortem interval; TBI, traumatic brain injury; w, women; m, men; sec, seconds; min, minutes; d, days; n.d., no documentation. (XLSX 15 kb)
414_2017_1768_MOESM2_ESM.xlsx (14 kb)
Table S2: Clinical and pathological characteristics of the individuals served as control cases. ISS, injury severity score; CPR, cardiopulmonary resuscitation; g; grams; h, hours; PMI, postmortem interval; w, women; m, men; min, minutes. (XLSX 13 kb)
414_2017_1768_MOESM3_ESM.xls (32 kb)
Table S3: Results of rank correlation calculation between the five markers of acute phase response and the hemolytic index as well as the postmortem interval in cerebrospinal fluid (CSF) and serum. (XLS 32 kb)


  1. 1.
    Faul M, Coronado V (2015) Epidemiology of traumatic brain injury. Handb Clin Neurol 127:3–13. CrossRefPubMedGoogle Scholar
  2. 2.
    Roth P, Farls K (2000) Pathophysiology of traumatic brain injury. Crit Care Nurs Q 23(3):14–25. CrossRefPubMedGoogle Scholar
  3. 3.
    Ondruschka B, Pohlers D, Sommer G, Schober K, Teupser D, Franke H, Dressler J (2013) S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases. J Neurotrauma 30(22):1862–1871. CrossRefPubMedGoogle Scholar
  4. 4.
    da Silva Meirelles L, Simon D, Regner A (2017) Neurotrauma: the crosstalk between neurotrophins and inflammation in the acutely injured brain. Int J Mol Sci 18(5):E1082.
  5. 5.
    Ziebell JM, Morganti-Kossmann MC (2010) Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7(1):22–30. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Woodcock T, Morganti-Kossmann MC (2013) The role of markers of inflammation in traumatic brain injury. Front Neurol 4:18.
  7. 7.
    Liao Y, Liu P, Guo F, Zhang ZY, Zhang Z (2013) Oxidative burst of circulating neutrophils following traumatic brain injury in human. PLoS One 8(7):e68963. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15(2):74–80. CrossRefPubMedGoogle Scholar
  9. 9.
    Helmy A, De Simoni MG, Guilfoyle MR, Carpenter KL, Hutchinson PJ (2011) Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury. Prog Neurobiol 95(3):352–372. CrossRefPubMedGoogle Scholar
  10. 10.
    Amick JE, Yandora KA, Bell MJ, Wisniewski SR, Adelson PD, Carcillo JA, Janesko KL, DeKosky ST, Carlos TM, Clark RS, Kochanek PM (2001) The Th1 versus Th2 cytokine profile in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr Crit Care Med 2(3):260–264. CrossRefPubMedGoogle Scholar
  11. 11.
    Kadhim HJ, Duchateau J, Sébire G (2008) Cytokines and brain injury: invited review. J Intensive Care Med 23(4):236–249. CrossRefPubMedGoogle Scholar
  12. 12.
    Kossmann T, Hans VH, Imhof HG, Stocker R, Grob P, Trentz O, Morganti-Kossmann MC (1995) Intrathecal and serum interleukin-6 and the acute phase response in patients with severe traumatic brain injuries. Shock 4(5):311–317CrossRefPubMedGoogle Scholar
  13. 13.
    Hans VH, Kossmann T, Joller H, Otto V, Morganti-Kossmann MC (1999) Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma. Neuroreport 10(2):409–412. CrossRefPubMedGoogle Scholar
  14. 14.
    Ferreira LC, Regner A, Miotto KD, Moura S, Ikuta N, Vargas AE, Chies JA, Simon D (2014) Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury. Brain Inj 28(10):1311–1316. CrossRefPubMedGoogle Scholar
  15. 15.
    Lustenberger T, Kern M, Relja B, Wutzler S, Störmann P, Marzi I (2015) The effect of brain injury on the inflammatory response following severe trauma. Immunobiology 221(3):427–431.
  16. 16.
    Nagatsu T, Sawada M (2005) Inflammatory process in Parkinson’s disease: role for cytokines. Curr Pharm Des 11(8):999–1016. CrossRefPubMedGoogle Scholar
  17. 17.
    Palmiere C, Mangin P (2012) Postmortem chemistry update part II. Int J Legal Med 126(2):199–215. CrossRefPubMedGoogle Scholar
  18. 18.
    Tsokos M (2007) Postmortem diagnosis of sepsis. Forensic Sci Int 165(2-3):155–164. CrossRefPubMedGoogle Scholar
  19. 19.
    Liu HD, Li W, Chen ZR, Zhou ML, Zhuang Z, Zhang DD, Zhu L, Hang CH (2013) Increased expression of ferritin in cerebral cortex after human traumatic brain injury. Neurol Sci 34(7):1173–1180. CrossRefPubMedGoogle Scholar
  20. 20.
    Newell E, Shellington DK, Simon DW, Bell MJ, Kochanek PM, Feldman K, Bayir H, Aneja RK, Carcillo JA, Clark RS (2015) Cerebrospinal fluid markers of macrophage and lymphocyte activation after traumatic brain injury in children. Pediatr Crit Care Med 16(6):549–557. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Simon D, Nicol JM, Sabino da Silva S, Graziottin C, Silveira PC, Ikuta N, Regner A (2014) Serum ferritin correlates with Glasgow coma scale scores and fatal outcome after severe traumatic brain injury. Brain Inj 29(5):612–617.
  22. 22.
    Maier B, Lehnert M, Laurer HL, Mautes AE, Steudel WI, Marzi I (2006) Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury. Shock 26(2):122–127. CrossRefPubMedGoogle Scholar
  23. 23.
    Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO, Agartz I, Aukrust P, Andreassen OA (2013) Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res 145(1-3):36–42. CrossRefPubMedGoogle Scholar
  24. 24.
    Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV (2010) Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer’s disease. J Alzheimers Dis 22(4):1305–1311. CrossRefPubMedGoogle Scholar
  25. 25.
    Astrup BS, Thomsen JL (2007) The routine use of C-reactive protein in forensic investigations. Forensic Sci Int 172(1):49–55. CrossRefPubMedGoogle Scholar
  26. 26.
    Vázquez MD, Sánchez-Rodriguez F, Osuna E, Diaz J, Cox DE, Pérez-Cárceles MD, Martinez P, Luna A, Pounder DJ (1995) Creatine kinase BB and neuron-specific enolase in cerebrospinal fluid in the diagnosis of brain insult. Am J Forensic Med Pathol 16(3):210–214. CrossRefPubMedGoogle Scholar
  27. 27.
    Osuna E, Pérez-Cárceles MD, Luna A, Pounder DJ (1992) Efficacy of cerebro-spinal fluid biochemistry in the diagnosis of brain insult. For Sci Int 52(2):193–198Google Scholar
  28. 28.
    Li DR, Michiue T, Zhu BL, Ishikawa T, Quan L, Zhao D, Yoshida C, Chen JH, Wang Q, Komatsu A, Azuma Y, Maeda H (2009) Evaluation of postmortem S100B levels in the cerebrospinal fluid with regard to the cause of death in medicolegal autopsy. Legal Med (Tokyo) Suppl 1: S273–S275.
  29. 29.
    Krohn M, Dreßler J, Bauer M, Schober K, Franke H, Ondruschka B (2015) Immunohistochemical investigation of S100 and NSE in cases of traumatic brain injury and its application for survival time determination. J Neurotrauma 32(7):430–440. CrossRefPubMedGoogle Scholar
  30. 30.
    Teasdale G, Jennet B (1974) Assessment of coma and impaired consciousness. Lancet 2(7872):81–84CrossRefPubMedGoogle Scholar
  31. 31.
    Osler T, Baker SP, Long W (1997) A modification of the injury severity score that both improves accuracy and simplifies scoring. J Trauma 43(6):922–926. CrossRefPubMedGoogle Scholar
  32. 32.
    Müller K, Elverland A, Rommer B, Waterloo K, Langbakk B, Undén J, Ingebrigtsen T (2006) Analysis of protein S-100B in serum: a methodological study. Clin Chem Lab Med 44(9):1111–1114. CrossRefPubMedGoogle Scholar
  33. 33.
    Mimasaka S, Hashiyada M, Nata M, Funayama M (2001) Correlation between serum IL-6 levels and death: usefulness in diagnosis of “traumatic shock”? Tohuko J Exp Med 193(4):319–324CrossRefGoogle Scholar
  34. 34.
    Tsokos M, Reichelt U, Jung R, Nierhaus A, Püschel K (2001) Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period. For Sci Int 119(1):47–56Google Scholar
  35. 35.
    Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A (1999) The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am J Emerg Med 17(6):548–551. CrossRefPubMedGoogle Scholar
  36. 36.
    Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, Kishimoto T (1995) Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91(5):1520–1524. CrossRefPubMedGoogle Scholar
  37. 37.
    Petzold A, Worthington V, Appleby I, Kerr ME, Kitchen N, Smith M (2011) Cerebrospinal fluid ferritin levels, a sensitive diagnostic test in late-presenting subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 20(6):489–493. CrossRefPubMedGoogle Scholar
  38. 38.
    Carbonell T, Rama R (2007) Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr Med Chem 14(8):857–874. CrossRefPubMedGoogle Scholar
  39. 39.
    Keir G, Tasdemir N, Thompson EJ (1993) Cerebrospinal fluid ferritin in brain necrosis: evidence for local synthesis. Clin Chim Acta 216(1-2):153–166. CrossRefPubMedGoogle Scholar
  40. 40.
    Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G (2003) Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34(12):2964–2969. CrossRefPubMedGoogle Scholar
  41. 41.
    Dreßler J, Hanisch U, Kuhlisch E, Geiger KD (2007) Neuronal and glial apoptosis in human traumatic brain injury. Int J Legal Med 121(5):365–375. CrossRefPubMedGoogle Scholar
  42. 42.
    Park YH, Jeong MS, Jang SB (2016) Structural insights of homotypic interaction domains in the ligand-receptor signal transduction of tumor necrosis factor (TNF). BMB Rep 49(3):159–166. CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Ng I, Yeo TT, Tang WY, Soong R, Ng PY, Smith DR (2000) Apoptosis occurs after cerebral contusions in humans. Neurosurgery 46(4):949–956Google Scholar
  44. 44.
    Hausmann R, Biermann T, Wiest I, Tübel J, Betz P (2004) Neuronal apoptosis following human brain injury. Int J Legal Med 118(1):32–36. CrossRefPubMedGoogle Scholar
  45. 45.
    Schrag B, Roux-Lombard P, Schneiter D, Vaucher P, Mangin P, Palmiere C (2012) Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalities. Int J Legal Med 126(4):505–512. CrossRefPubMedGoogle Scholar
  46. 46.
    Mulder SD, Hack CE, van der Flier WM, Scheltens P, Blankenstein MA, Veerhuis R (2010) Evaluation of intrathecal serum amyloid P (SAP) and C-reactive protein (CRP) synthesis in Alzheimer’s disease with the use of index values. J Alzheimers Dis 22(4):1073–1079. CrossRefPubMedGoogle Scholar
  47. 47.
    Maeda H, Zhu BL, Ishikawa T, Quan L, Michiue T (2009) Significance of postmortem biochemistry in determining the cause of death. Legal Med (Tokyo) 11:S46–S49.
  48. 48.
    Hanrieder J, Wetterhall M, Enblad P, Hillered L, Bergquist J (2009) Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J Neurosci Methods 177(2):469–478. CrossRefPubMedGoogle Scholar
  49. 49.
    Papa L, Wang KKW (2017) Raising the bar for traumatic brain injury biomarker research: methods make a difference. J Neurotrauma 34(13):2187–2189. CrossRefPubMedGoogle Scholar
  50. 50.
    Kawata K, Liu CY, Merkel SF, Ramirez SH, Tierney RT, Langford D (2016) Blood biomarkers for brain injury: what are we measuring? Neurosci Biobehav Rev 68:460–473. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Benjamin Ondruschka
    • 1
  • Sandra Schuch
    • 1
  • Dirk Pohlers
    • 2
  • Heike Franke
    • 3
  • Jan Dreßler
    • 1
  1. 1.Institute of Legal MedicineMedical Faculty University of LeipzigLeipzigGermany
  2. 2.Center of Diagnostics GmbHKlinikum ChemnitzChemnitzGermany
  3. 3.Rudolf Boehm Institute of Pharmacology and ToxicologyMedical Faculty University of LeipzigLeipzigGermany

Personalised recommendations